Meyahealth
HomeGeneticsConditionSTXBP1 encephalopathy
Back to Condition
STXBP1 encephalopathy
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

STXBP1 Encephalopathy

STXBP1 encephalopathy is a genetic condition characterized by abnormal brain function, intellectual disability, and often recurrent seizures, typically beginning in infancy.

Overview

STXBP1 encephalopathy is a condition characterized by abnormal brain function (encephalopathy) and intellectual disability. Most affected individuals also have recurrent seizures (epilepsy). The signs and symptoms of this condition typically begin in infancy but can start later in childhood or early adulthood.

In many affected individuals who have epilepsy, the seizures stop after a few years, and the other neurological problems continue throughout life. However, some people with STXBP1 encephalopathy have seizures that persist.

Symptoms & Clinical Features

In people with STXBP1 encephalopathy, intellectual disability is often severe to profound. In addition, speech and motor skills, such as sitting, crawling, and walking, can be delayed. Though they may acquire the skill late, many children with the condition can walk independently by age 5. Affected individuals usually learn their first words later than their peers, sometimes not until late childhood. Some can communicate verbally using simple sentences, while others never develop the skill.

Epilepsy and Seizure Types

About 85 percent of people with STXBP1 encephalopathy develop epilepsy. The most common seizures in this condition are infantile spasms, which occur before age 1 and consist of involuntary muscle contractions. Other seizure types that can occur in people with this condition include:

  • Uncontrolled muscle twitches (myoclonic seizures)
  • Sudden episodes of weak muscle tone (atonic seizures)
  • Partial or complete loss of consciousness (absence seizures)
  • Loss of consciousness with muscle rigidity and convulsions (tonic-clonic seizures)

Most people who have STXBP1 encephalopathy have more than one type of seizure. In about one-quarter of affected individuals, the seizures are described as refractory because they do not respond to therapy with anti-epileptic medications.

Other Neurological Problems

Other neurological problems that occur in people with STXBP1 encephalopathy include:

  • Features of autism spectrum disorder
  • Weak muscle tone (hypotonia)
  • Movement problems, such as difficulty coordinating movements (ataxia), involuntary trembling (tremors), and muscle stiffness (spasticity)
  • Areas of brain tissue loss (atrophy) found on medical imaging in some cases

Causes & Genetics

As its name indicates, STXBP1 encephalopathy is caused by mutations in the STXBP1 gene. This gene provides instructions for making syntaxin-binding protein 1. In nerve cells, this protein helps regulate the release of chemical messengers called neurotransmitters from compartments known as synaptic vesicles. The release of neurotransmitters relays signals between neurons and is critical for normal brain function. Syntaxin-binding protein 1 is also thought to play a role in the positioning and growth of neurons during brain development.

STXBP1 gene mutations reduce the amount of functional protein produced from the gene, which impairs the release of neurotransmitters. A change in neurotransmitter levels can lead to uncontrolled activation (excitation) of neurons, which causes seizures. Research suggests that a shortage of syntaxin-binding protein 1 also impairs neuron development in the brain, which could underlie encephalopathy and other neurological problems characteristic of this condition.

Inheritance

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Most cases of this condition result from new (de novo) mutations in the gene that occur during the formation of reproductive cells (eggs or sperm) in an affected individual’s parent or in early embryonic development. These cases occur in people with no history of the disorder in their family.

Frequency

The prevalence of STXBP1 encephalopathy with epilepsy is unknown. More than 280 individuals with this condition have been reported in the medical literature.

Other Names for This Condition

  • DEE4
  • Developmental and epileptic encephalopathy 4
  • Developmental and epileptic encephalopathy, type 4
  • Early-infantile epileptic encephalopathy 4
  • EIEE4
  • STXBP1 encephalopathy with epilepsy
  • STXBP1 epileptic encephalopathy
  • STXBP1-related developmental and epileptic encephalopathy
  • STXBP1-related early-onset encephalopathy
  • STXBP1-related epileptic encephalopathy

Frequently Asked Questions

Diagnosis of STXBP1 encephalopathy is confirmed through genetic testing, specifically by identifying a pathogenic variant (mutation) in the STXBP1 gene. This is often done using next-generation sequencing techniques like whole exome sequencing or a targeted gene panel for epilepsy or developmental disorders.
Caregivers should be trained to recognize the specific types of seizures their child experiences and to administer rescue medications as prescribed for prolonged or cluster seizures. It's important to have an emergency action plan developed with the child's neurologist, including when to seek immediate medical attention, such as for status epilepticus (a prolonged seizure or series of seizures without recovery).
Treatment primarily focuses on managing seizures with anti-seizure medications, which may need to be adjusted frequently due to the variety and persistence of seizure types. There is no specific cure, so other neurological symptoms like intellectual disability and motor delays are managed through comprehensive supportive therapies including physical, occupational, and speech therapy, as well as educational support.
Children with STXBP1 encephalopathy benefit from early and intensive intervention programs. This includes physical therapy to improve motor skills like sitting and walking, occupational therapy to enhance fine motor skills and daily living activities, and speech therapy to develop communication abilities, which can range from verbal language to alternative communication methods. Special education services are also crucial to address intellectual disability.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA

About UsTerms & PolicyFAQ